Atlas Trials

Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Clinical trial NCT02772965 · COMPLETED

Trial details

NCT number
NCT02772965
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pediatric Crohn's Disease
Start date
2016-10-01
Primary completion
2022-04-07
Enrollment
306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.